Saito Y, Kaneko M, Kirihara Y, Sakura S, Kosaka Y
Department of Anesthesiology, Shimane Medical University, Japan.
Anesthesiology. 1998 Dec;89(6):1464-70. doi: 10.1097/00000542-199812000-00024.
There has been little information regarding the effects of local anesthetics on tolerance to opioids, although chronic use of combination of opioids and local anesthetics is popular for pain control. This study was designed to examine the effects of lidocaine on morphine tolerance to somatic and visceral antinociception.
Rats received a continuous intrathecal infusion of morphine (0.3-10 microg x kg(-1) x h(-1)), lidocaine (30-1000 microg x kg(-1). h(-1)), a combination of those, or saline. After 6- day infusion, intrathecal morphine challenge test (5 microg/10 microl) was performed, and time-response curve was constructed to assess the magnitude of tolerance. The tail flick (TF) test and colorectal distension (CD) test were used to measure somatic and visceral antinociceptive effects, respectively.
Antinociceptive effects in the TF and CD tests caused by morphine challenge were reduced (P < 0.01) in the morphine infused groups. The magnitude of the tolerance was inversely associated with the amount of morphine infused. Lidocaine infusion induced no different change in the morphine challenge test from that seen in the saline infusion group. Development of tolerance was greater in morphine 3 microg x kg(-1) h(-1) than in morphine 0.75 microg x kg(-1) x h(-1) + lidocaine 150 microg x kg(-1) x h(-1) despite their similar antinociceptive effects during intrathecal infusion. The infusion of a low dose of morphine (0.3 microg kg(-1) x h(-1)) did not reduce the antinociceptive effects in the challenge test.
Lidocaine in combination with morphine does not reduce tolerance to morphine nor develop cross-tolerance. The intrathecal infusion of morphine induced tolerance to somatic and visceral antinociception in a dose-dependent fashion.
尽管阿片类药物与局部麻醉药联合长期使用在疼痛控制中很常见,但关于局部麻醉药对阿片类药物耐受性影响的信息却很少。本研究旨在探讨利多卡因对吗啡躯体和内脏抗伤害感受耐受性的影响。
大鼠接受鞘内持续输注吗啡(0.3 - 10微克·千克⁻¹·小时⁻¹)、利多卡因(30 - 1000微克·千克⁻¹·小时⁻¹)、两者的组合或生理盐水。输注6天后,进行鞘内吗啡激发试验(5微克/10微升),并构建时间 - 反应曲线以评估耐受性的程度。分别采用甩尾(TF)试验和结直肠扩张(CD)试验来测量躯体和内脏抗伤害感受作用。
吗啡输注组中,吗啡激发试验在TF和CD试验中引起的抗伤害感受作用降低(P < 0.01)。耐受性的程度与输注的吗啡量呈负相关。利多卡因输注在吗啡激发试验中引起的变化与生理盐水输注组无差异。尽管鞘内输注期间吗啡3微克·千克⁻¹·小时⁻¹和吗啡0.75微克·千克⁻¹·小时⁻¹ + 利多卡因150微克·千克⁻¹·小时⁻¹的抗伤害感受作用相似,但吗啡3微克·千克⁻¹·小时⁻¹组的耐受性发展比吗啡0.75微克·千克⁻¹·小时⁻¹ + 利多卡因150微克·千克⁻¹·小时⁻¹组更大。低剂量吗啡(0.3微克·千克⁻¹·小时⁻¹)输注在激发试验中未降低抗伤害感受作用。
利多卡因与吗啡联合使用不会降低对吗啡的耐受性,也不会产生交叉耐受性。鞘内输注吗啡以剂量依赖性方式诱导对躯体和内脏抗伤害感受的耐受性。